Mirion appoints Dr. Sheila Rege to board, replacing Warren

Mirion Technologies, Inc.

Christopher Warren resigned from Mirion's Board effective Sept 16, 2022; departure not due to any disagreement.
Dr. Sheila Rege appointed to Board effective Sept 16, 2022, filling Warren's vacancy; will stand for reelection in 2023.
Dr. Rege is a board-certified radiation oncologist, CEO/Founder of Northwest Cancer Clinic, with 30+ years in nuclear medicine.
Chairman L.D. Kingsley cited goal to grow Medical segment to at least 50% of total company revenue.
Dr. Rege will receive standard non-employee director compensation and serve on Audit and Compensation Committees.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christopher Warren

Director

MIR · Mirion Technologies, Inc.

Effective: 2022-09-16
Successor: Sheila Rege
Filed: September 19, 2022, 7:59 PM ET

On September 13, 2022, Christopher Warren, a member of the board of directors (the “Board”) of Mirion Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective at the close of business on September 16, 2022.

Appointed

Sheila Rege

Director

MIR · Mirion Technologies, Inc.

Effective: 2022-09-16
Filed: September 19, 2022, 7:59 PM ET

On September 16, 2022, after recommendation by the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Sheila Rege, M.D., as a member of the Board, effective immediately, to fill the vacancy created by Mr. Warren’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Warren resigned as Director at Mirion Technologies, Inc..

Action: resigned
Role: Director

Exact text from the filing

On September 13, 2022, Christopher Warren, a member of the board of directors (the “Board”) of Mirion Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective at the close of business on September 16, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sheila Rege was appointed as Director at Mirion Technologies, Inc..

Action: appointed
Role: Director

Exact text from the filing

On September 16, 2022, after recommendation by the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Sheila Rege, M.D., as a member of the Board, effective immediately, to fill the vacancy created by Mr. Warren’s resignation.

View on SEC.gov

Mirion Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-025095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.